Major Pharmaceutical companies worldwide use Fusion QbD every day to develop truly robust and transferrable methods. Regulatory agencies use Fusion QbD to modernize methods and to challenge robustness claims in Pharma company submittals! These proven capabilities are now available to you as a QbD Method Development Service!

The only software platform with a complete and perfect integration of Design of Experiments methodology (DOE), Chromatography Modeling, and Experiment Automation on Agilent, Thermo, and Waters LC systems for fully automated walkaway experimenting. Fusion QbD Supports all Phases of LC Method Development

Fusion QbD预测将产生“总体最佳答案 (BOA)”或最大峰计数的方法变量组合（pH、色谱柱、梯度时间）。 完成快速筛选研究后，将这些变量用于方法优化。

The perfect QbD software for formulation & process development – automated experimental design selection, sophisticated analysis tools, including automated modeling and simulation, comprehensive reporting, with a full 21 CFR 11 compliance toolset.

Fusion QbD成功用于生物药的方法开发，首先生成HILIC和 阳离子交换 模式的DoE实验设计。 然后使用Fusion中的导出功能，在Empower中自动创建DoE设计好的仪器方法和样品组。

Fusion QbD软件内置统计学数据建模功能，能够为研究人员设计科学的分析方法开发实验方案，直接与仪器软件进行交互，直接分析结果数据。 分析研究人员无需统计学知识即可完成一个基于QbD的分析方法开发过程。 本次线上讲座将为您演示这一过程。

Fusion QbD is the only software designed for the development of chromatographic methods that uses the real and complete QbD package aligned with ICH Q8 (R2). All predictions are based on empirical models generated from experimental raw data, not theoretic “first principle” functions or in-house algorithms.

2024年2月9日 · Empower Tip #179：使用 Empower 和 Fusion QbD 自动执行色谱柱选择和初始方法条件. 这篇 Empower 贴文将演示在 Empower 中，如何在色谱柱筛选实验中通过自动选择色谱柱及初始方法条件，实现方法生命周期管理 (MLCM)。 如果没有基于风险的统计方法，确定理想的色谱柱和初始方法条件可能既耗时，又充满挑战。 Waters Corporation 的 Tran Pham 和 S-Matrix（Fusion QbD 的制造商）的 Richard Verseput 讨论了 Empower 和 Fusion QbD 结合的 …

S-Matrix Fusion QbD ® - The only software that combines chromatography modelling and DoE* in a single tool. Adopt ICH Q2 (R2) and Q14 now, and get ready for Analytical Procedure Lifecycle Management (APLM) with Fusion QbD:

10 小时之前 · In this case study, analytical method optimization with Fusion QbD software for a synthetic peptide and small molecule API is discussed.